Search
25/06/2024
What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?
Lleó, A, Alcolea, D. What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?. NEUROLOGY. 2024; 102(12)DOI:10.1212/WNL.0000000000209505. PMID:38830183. IF:8.500(Q1/1D).
25/06/2024
Persistence of viable but nonculturable Legionella pneumophila state in hospital water systems: A hidden enemy? (vol 927, 172410, 2024)
Párraga-Niño, N, Cortès-Tarragó, R, Quero, S, Garcia-Núñez, M, Arqué, E, Sabaté, S, Ramirez, D, Gavaldà, L. Persistence of viable but nonculturable Legionella pneumophila state in hospital water systems: A hidden enemy? (vol 927, 172410, 2024). The Science of the total environment. 2024; 931DOI:10.1016/j.scitotenv.2024.173008. PMID:38729807. IF:8.000(Q1/2D).
24/06/2024
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project
González-Muñoza, C, Calafat, M, Gisbert, JP, Iglesias, E, Minguez, M, Sicilia, B, Aceituno, M, Gomollón, F, Calvet, X, Ricart, E, De Castro, L, Rivero, M, Mesonero, F, Márquez, L, Nos, P, Rodriguez-Pescador, A, Guardiola, J, García-Sepulcre, M, García-López, S, Lorente-Poyatos, RH, Alba, C, Sánchez-Ocaña, R, Vera, I, Madero, L, Riestra, S, Navarro-Llavat, M, Pérez-Calle, JL, Camps, B, Van Domselaar, M, Lucendo, AJ, Martin-Arranz, MD, Montoro-Huguet, MA, Sierra-Ausin, M, Llao, J, Carpio, D, Varela, P, Merino, O, Fernandez-Salazar, L, Piqueras, M, Sese, E, Busquets, D, Tardillo, C, Maroto, N, Riera, J, Martinez-Flores, C, Munoz, F, Gordillo-abalos, J, Bertoletti, F, Garcia-Planella, E, Domènech, E. Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project. POSTGRADUATE MEDICAL JOURNAL. 2024; DOI:10.1093/postmj/qgae076. PMID:38913019. IF:2.700(Q1/3D).
24/06/2024
Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies
Fox, ML, García-Cadenas, I, Navarro, V, Martínez, AP, Kara, M, Bazán, IS, Coll, CF, Bailén, R, Bento, L, Parody, R, Esquirol, A, Orti, G, Mussetti, A, Salamero, O, Martino, R, González, AP, Barba, P, Kwon, M, Solano, C, Bosch, F, Valcárcel, D. Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies. BONE MARROW TRANSPLANTATION. 2024; 59(10)DOI:10.1038/s41409-024-02322-2. PMID:38914883. IF:5.200(Q1/1D).